Compare BFIN & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BFIN | ALEC |
|---|---|---|
| Founded | 1924 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.8M | 133.2M |
| IPO Year | N/A | 2019 |
| Metric | BFIN | ALEC |
|---|---|---|
| Price | $12.35 | $1.45 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 7 |
| Target Price | ★ $11.50 | $3.33 |
| AVG Volume (30 Days) | 58.4K | ★ 1.6M |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | ★ 3.23% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | $46,495,000.00 | ★ $69,048,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.15 | $160.66 |
| P/E Ratio | $66.53 | ★ N/A |
| Revenue Growth | N/A | ★ 12.26 |
| 52 Week Low | $10.69 | $0.87 |
| 52 Week High | $13.58 | $3.40 |
| Indicator | BFIN | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 53.80 | 52.46 |
| Support Level | $12.43 | $1.34 |
| Resistance Level | $13.01 | $1.49 |
| Average True Range (ATR) | 0.21 | 0.10 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 28.26 | 75.00 |
BankFinancial Corp is a full-service, national bank providing banking, financial planning and fiduciary services to individuals, families and businesses in the Chicago metropolitan area and on a regional or national basis for commercial finance, healthcare finance, equipment finance, commercial real estate finance and treasury management business customers. The Bank offers its customers a broad range of loan, deposit, trust and other financial products and services through approximately 18 full-service banking offices located in Cook, DuPage, Lake and Will Counties, Illinois and through its Internet Branch.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.